PHAT · smart money activity

Who's buying Phathom Pharmaceuticals, Inc.?

Phathom Pharmaceuticals, Inc. has 1 recent smart-money filing on record (13D), the latest on Nov 2, 2026.

Smart money score Score and rank in Pro

Latest filingNov 2, 2026

Independent buyers1

Signal sources13D

Insiders' avg buy price Pro

PHAT insider buying, 13F and 13D filings

Filed Nov 2, 202613D stake (no activist plan)

Frazier Life Sciences Public Fund, L.P. (with 16 co-filers): Amended Schedule 13D: 7.4% stake

View the filing on SEC EDGAR ↗

PHAT's score and rank are in Pro, with alerts when the next filing lands.

Try Pro free for 7 days

Signals come from SEC filings: Form 4 (insiders, filed within 2 business days), 13F (fund holdings, up to 45 days after quarter end) and Schedule 13D (5%+ activist stakes). This page reports what the filings show; it is not investment advice.